Sunaric-Mégevand G, Leuenberger P M
Division of Ophthalmology, University Hospital Geneva, Geneva, Switzerland.
Am J Ophthalmol. 2001 Aug;132(2):221-8. doi: 10.1016/s0002-9394(01)00972-2.
Viscocanalostomy is a nonperforating filtering surgical procedure that may avoid postoperative complications common with standard trabeculectomy. This study was conducted to determine the surgical outcome of this procedure after a postoperative observation period of 12 to 36 months.
Interventional consecutive case series. In a prospective study, a consecutive series of 67 eyes of 67 patients with chronic primary open-angle glaucoma underwent VCS. Excluded were patients with angle closure glaucoma, post-traumatic, uveitic, neovascular, or dysgenetic glaucoma, as well as patients who needed combined cataract-glaucoma procedures. The patients were examined postoperatively on the first day, first week, at 1 month, and then at 3-month intervals through 36 months. At each visit, best-corrected visual acuity, intraocular pressure (IOP), and the appearance of the surgical wound, anterior chamber, and indirect funduscopy were recorded.
Complete success was defined as IOP less than or equal to 20 mm Hg and greater than or equal to 30% IOP reduction without medical or additional surgical treatment compared with the IOP from a preoperative level with maximum tolerated medical therapy; qualified success IOP less than or equal to 20 mm Hg with treatment or an IOP reduction less than 30% from preoperative level with maximum tolerated medical therapy; and qualified failure of an IOP greater than 20 mm Hg with glaucoma medication, but no optic nerve or visual field deterioration and complete failure as an eye requiring further glaucoma surgery or lost visual function. The overall success rate was 88% at 1 year, 90% at 2 years, and 88% at 3 years, with a complete success of 68% at 1 year, 60% at 2 and 59% at 3 years. Four eyes had a perforation of the Descemet membrane, three of those needed peripheral iridectomy; six eyes had a microperforation not needing a peripheral iridectomy. Five eyes presented hyphema. Eight eyes presented deterioration of visual function after surgery: three eyes because of corneal astigmatism, one eye because of cataract, and four presented glaucomatous deterioration of the visual field despite pressures under 20 mm Hg. Four eyes had progressive cataract formation judged as independent from surgery.
VCS provides an overall success rate of 88% and a complete success of 59% 3 years after surgery. The major immediate complication is perforation of the Descemet membrane with a need for peripheral iridectomy. No serious long-term complications were noted in our small series. Visual function remained stable in 55 eyes (82%).
粘小管切开术是一种非穿透性滤过性手术,可避免标准小梁切除术常见的术后并发症。本研究旨在确定该手术在术后12至36个月观察期后的手术效果。
干预性连续病例系列。在一项前瞻性研究中,连续67例慢性原发性开角型青光眼患者的67只眼接受了粘小管切开术(VCS)。排除闭角型青光眼、外伤性、葡萄膜炎性、新生血管性或发育性青光眼患者,以及需要白内障青光眼联合手术的患者。术后第1天、第1周、1个月,然后每3个月间隔至36个月对患者进行检查。每次就诊时,记录最佳矫正视力、眼压(IOP)以及手术伤口、前房和间接眼底镜检查的外观。
完全成功定义为眼压小于或等于20 mmHg,与术前最大耐受药物治疗时的眼压相比,眼压降低大于或等于30%,无需药物或额外手术治疗;合格成功定义为眼压小于或等于20 mmHg且接受治疗,或与术前最大耐受药物治疗时的眼压相比,眼压降低小于30%;合格失败定义为使用青光眼药物治疗后眼压大于20 mmHg,但无视神经或视野恶化,完全失败定义为需要进一步青光眼手术或视力丧失的眼。1年时总体成功率为88%,2年时为90%,3年时为88%,1年时完全成功率为68%,2年时为60%,3年时为59%。4只眼发生后弹力层穿孔,其中3只需要周边虹膜切除术;6只眼发生微小穿孔,无需周边虹膜切除术。5只眼出现前房积血。8只眼术后视力功能恶化:3只眼因角膜散光,1只眼因白内障,4只眼尽管眼压低于20 mmHg仍出现青光眼性视野恶化。4只眼出现与手术无关的进行性白内障形成。
粘小管切开术术后3年总体成功率为88%,完全成功率为59%。主要的即刻并发症是后弹力层穿孔,需要周边虹膜切除术。在我们的小样本系列中未发现严重的长期并发症。55只眼(82%)的视力功能保持稳定。